Topics
	Abuse Liability
	Bioavailability and Bioequivalence
	Chemical Entity Products/Quality
	Clinical Trials
	Cost Recovery
	Common Technical Document (CTD)
	Disinfectants
	Drug Interactions
	Drug Product Formulation
	Drug Submission Status
	Drugs Currently Regulated as New Drugs
	Good Manufacturing Practices
	Haemodialysis
	Helicobacter pylori
	Homeopathics
	Hormone Replacement Therapy
	International Conference on Harmonisation (ICH)
	Management of Drug Submissions
	Metered Dose Inhalers
	Non-Medicinal Ingredients Nomenclature
	Nonprescription Drugs: Category IV Monograph
	Nonprescription Drugs: Labelling Standards - Drug Product
	Notice of Compliance with Conditions
	Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
	Official Methods
	Oral Contraceptive
	Patented Medicine
	Pharmacogenomics
	Preparation of DIN Submission
	Priority Review
	Product Monograph
	QT/QTc Interval Prolongation
	Reconsideration of Final Decisions
	Traditional Herbal Medicine

Guidance Documents

Guidance documents have been prepared to assist in the interpretation of policies and governing statutes and regulations. They are intended to assist in preparing drug submissions when seeking an approval to sell a drug product in Canada.

Draft Guidance For Industry - Marketed Health Product Name Assessment: Look-alike Sound-alike (LA/SA) Health Product Names
Date: 2005-11-24

Guidance for Industry: Drug Name Review: Look-alike Sound-alike (LA/SA) Health Product Names
Date: 2005-10-31